Genotype-specific Dose Optimization

Genotype-Specific Dose Optimization is a mutagen dose optimization strategy that tailors mutagen exposure levels to the genetic makeup of a specific genotype, distinguishing it from generalized dose approaches by prioritizing genotype-dependent sensitivity and response variability in mutation induction.

6

Publications

423

Citations

56

Authors

31

Institutions

Publications per year

2017–2026

3

Authors

56

  1. AO
    Adeniyi Olagunju

    University of Liverpool, United Kingdom

    1 publications · 37 citations

    1

    h-index

  2. BM
    Boluwatife M. OlaOlorun

    University of KwaZulu-Natal, South Africa

    1 publications · 25 citations

    1

    h-index

  3. KF
    Katsuya Fujimoto

    Hokkaido University, Japan

    1 publications · 222 citations

    1

    h-index

  4. TS
    T Shirasaka

    National Cancer Institute, United States

    1 publications · 222 citations

    1

    h-index

  5. MU
    Mikio Ueda

    Kanazawa University, Japan

    1 publications · 222 citations

    1

    h-index

1–5 of 56

Venues

  1. South African Journal of Plant and Soil

    1 publications · 25 citations

    1

    h-index

  2. PLoS ONE

    1 publications · 85 citations

    1

    h-index

  3. Inflammatory Bowel Diseases

    1 publications · 33 citations

    1

    h-index

  4. Trends in Biosciences/Trends in biosciences

    1 publications · 21 citations

    1

    h-index

  5. British Journal of Clinical Pharmacology

    BJCP · 1 publications · 37 citations

    1

    h-index

1–5